Medical Device Network on MSN
Alcon spends up to $200M to co-develop customisable cataract lenses with RxSight
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...
Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...
RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...
Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...
Eye Surgeons Associates is the first practice in Iowa to offer the Light-Adjustable Lens (LAL) by RxSight to cataract patients. Cataracts occur when the eye’s natural lens becomes clouded and rigid, ...
Please provide your email address to receive an email when new articles are posted on . TAMPA, Fla. — The Light Adjustable Lens optimizes postoperative results after cataract surgery, a speaker said ...
Nearly three million cataract surgeries are performed every year in the United States. The majority of patients must wear prescription glasses after the procedure to see properly. But a new technology ...
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--The latest development in cataract surgery is now available at several Northwell locations including Peconic Bay Medical Center, Syosset Surgical center and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results